Private Advisor Group’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
Other funds holding AVXL
PAM
AC
AA
SSWM
1WA
LA
AHL
CIC
OCG
FVWA
Private Advisor Group's AVXL Position: Q2 2026 in Review
Private Advisor Group increased its Anavex Life Sciences (AVXL) stake by 0.86% in Q2 2026, buying an estimated $12.7K and bringing the position to 504,000 shares worth $1.31M. The position accounts for 0.01% of the portfolio, ranked #1224.
Private Advisor Group first reported a position in AVXL in Q2 2020 and has held it in 19 quarters since. The position peaked at $4.05M in Q3 2025. 40 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.
- Private Advisor Group held 504,000 shares of Anavex Life Sciences worth $1.31M as of Q2 2026.
- Private Advisor Group bought 4,300 Anavex Life Sciences shares in Q2 2026, an estimated $12.7K.
- Anavex Life Sciences made up 0.01% of Private Advisor Group's portfolio in Q2 2026, its #1224 holding.
- Private Advisor Group first reported a position in Anavex Life Sciences in Q2 2020 and has held it in 19 quarters since.
- Private Advisor Group's Anavex Life Sciences position peaked at $4.05M in Q3 2025.
- 40 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.
Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.